Clinical Trial Update: Ivermectin Repurposed for the Treatment of PKDL [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating repurposed ivermectin for treating Post Kala Azar Dermal Leishmaniasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-kala-azar Dermal Leishmaniasis

Drugs mentioned

• IVERMECTIN (Ivermectin)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Post Kala Azar Dermal Leishmaniasis | EARLY_Phase 1 | Status: COMPLETED